Obesity medicine; define as within practice of medicine and allow physicians to prescribe obesity drugs via telemedicine.

HB 1136 defines obesity medicine as part of medical practice in Mississippi and allows physicians certified in obesity medicine to prescribe FDA-approved obesity drugs (including GLP-1 medications like Wegovy or Ozempic) via telemedicine. The bill amends telemedicine rules to explicitly include obesity medicine consultations and requires HIPAA-compliant technology for remote prescribing. This directly affects Mississippi physicians specializing in obesity care and patients seeking medication-based obesity treatment without in-person visits. The law mandates the State Board of Medical Licensure to create implementing rules, ensuring remote prescriptions follow state medical standards.